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Purpose: Medication non-adherence prevents patients from receiving the benefit of otherwise effective 
pharmacological therapy for hypertension. While many varied interventions have been tested to improve 
antihypertensive medication adherence, the overall and relative efficacy of the strategies developed to 
date is not known. 
Methods: We systematically reviewed randomized controlled trials testing the efficacy of medication 
adherence interventions for adults self-administering blood pressure-lowering medication. Our review 
included only studies which measured adherence by electronic monitoring, which provides the greatest 
amount of detail on patients’ dosing histories. Data from the studies were independently coded by two 
researchers, and random-effects meta-analysis was conducted for those studies reporting sufficient data 
for calculation of effect size. 
Results: Nine studies met our inclusion criteria (publication range: 1979—2010). Only seven studies 
reported sufficient data for inclusion in a meta-analysis. The mean adherence effect size (Cohen’s d) was 
0.377 (S.E. 0.059). Our review of results indicates that the clinical effect of antihypertensive adherence 
interventions remains small. Effects observed are often from preventing the lowering of adherence over 
time seen in control groups, rather than due to increasing adherence from baseline. 
Conclusions: Medication adherence interventions have the potential for creating positive improvement in 
patients’ antihypertensive adherence. Additional high-quality primary studies are needed to develop and 
test interventions better designed to generate greater improvement in adherence, leading to greater 
impact in measurable clinical outcomes. Effective interventions should then be moved into translational 
research and tested for effectiveness in ‘real-life’ clinical practice environments. 
 
 
